534 related articles for article (PubMed ID: 16805946)
21. Pharmacogenetics of classical and new antipsychotic drugs.
Otani K; Aoshima T
Ther Drug Monit; 2000 Feb; 22(1):118-21. PubMed ID: 10688273
[TBL] [Abstract][Full Text] [Related]
22. [Role of pharmacogenetics in psychopharmacotherapy].
Gram LF
Encephale; 1991; 17 Spec No 1():123-5. PubMed ID: 1864259
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 and its role in veterinary drug interactions.
Trepanier LA
Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):975-85, v. PubMed ID: 16984823
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacogenetics and tailored drug treatment in schizophrenia].
Andreassen OA; Steen VM
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450s in the development of target-based anticancer drugs.
Purnapatre K; Khattar SK; Saini KS
Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
[TBL] [Abstract][Full Text] [Related]
27. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
29. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
Kontijevskis A; Komorowski J; Wikberg JE
J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
Murray M
Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
[TBL] [Abstract][Full Text] [Related]
33. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
34. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
Saggar S; Maibach HI
Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
Johansson I; Ingelman-Sundberg M
Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
[TBL] [Abstract][Full Text] [Related]
38. Enzymes and pharmacogenetics of cardiovascular drugs.
Siest G; Jeannesson E; Visvikis-Siest S
Clin Chim Acta; 2007 May; 381(1):26-31. PubMed ID: 17362901
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.
Cressey TR; Lallemant M
Infect Genet Evol; 2007 Mar; 7(2):333-42. PubMed ID: 17045554
[TBL] [Abstract][Full Text] [Related]
40. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic.
Rendić S
Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
